The majority of women with epithelial ovarian cancer present the disease at a postmenopausal stage where circulating follicle stimulating hormone (FSH) and lutenizing hormone (LH) levels are elevated, indicating a causal relationship between chronically elevated gonadotropin levels and ovarian cancer development [5], [8]. Here, PLOD1 is linked to ovarian carcinoma.